Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-30 @ 7:34 AM
Study NCT ID:
NCT00769704
Status:
COMPLETED
Last Update Posted:
2016-07-13
First Post:
2008-10-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma
Sponsor:
BioVex Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-07
First Submit QC Date:
None
Study First Post Date:
2008-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-22
Results First Submit QC Date:
None
Results First Post Date:
2015-12-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-14
Last Update Post Date:
2016-07-13
Last Update Post Date Type:
ESTIMATED